A DOSE CONFIRMATION AND PHARMACOKINETIC STUDY OF PEGCRISANTASPASE ADMINISTERED AS INTRAVENOUS (IV) INFUSION IN CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) /LYMPHOBLASTIC LYMPHOMA (LBL). FOLLOWING HYPERSENSITIVITY TO PEGASPARGASE (ONCASPAR):